It is currently Wed Oct 22, 2014 8:47 am

News News of ThisIsMS

Site map of ThisIsMS » Forum : ThisIsMS

Welcome to the world's leading forum on Multiple Sclerosis research, support, and knowledge. For over 10 years, This is MS has provided an unbiased community dedicated to Multiple Sclerosis patients, caregivers, and affected loved ones.

Oral fumurate research

Read more : Oral fumurate research | Views : 1680 | Replies : 5 | Forum : Drug Pipeline


Harry Z - seminar on 28 May

Harry Z,

The MS Society of Canada has held a series of MS seminars across Canada. One is in London Ontario (not to be confused with London, the centre of the Universe, where I live). Harry Z lives in London and promised to attend and report back.

If you can pull yourself away from counting all the money you have made from investing in the MS drugs companies, please attend Harry. Arron said he would ...
Read more : Harry Z - seminar on 28 May | Views : 1015 | Replies : 2 | Forum : General Discussion


UK cannabis trial

The UK MS Society is seeking people with progressive MS to join a cannaboid trial.

http://www.mssociety.org.uk/go.rm?id=16658
Read more : UK cannabis trial | Views : 1012 | Replies : 0 | Forum : General Discussion




Conference in Baltimore

Dear all,

A link to Johns Hopkins PROJECT Restore. Also reference to a conference in Baltimore 19-23 July. Whilst it covers rare neurological problems, MS will also be covered.

Ian

http://hopkinsneuro.org/restore/
Read more : Conference in Baltimore | Views : 926 | Replies : 0 | Forum : General Discussion


TGN1412

Parexel Drug Trial Had Shortfalls, U.K. Investigation Says

Parexel International Corp., which ran a clinical trial that left six men with multiple organ failure earlier this year, didn't have a doctor with adequate training and experience screening the patients, the U.K. health regulator said.

Parexel, based in Waltham, Massachusetts, failed to ensure that closely held German biotechnology company TeGenero AG, which developed the medicine, had proper insurance to cover the volunteers, the London-based Medicines ...
Read more : TGN1412 | Views : 1200 | Replies : 0 | Forum : Drug Pipeline


Canadians and Vit D

TORONTO (CP) - Sunlight may be the easiest and most natural way to get a health-enhancing dose of vitamin D, but Canadians should know that a little sun goes a long way, says a Canada-U.S. consensus group formed to determine the risks and benefits of exposure to ultraviolet rays.

In what has turned out to be a delicate balancing act, the group is advising that while too much time in the sun raises the risk ...
Read more : Canadians and Vit D | Views : 4836 | Replies : 42 | Forum : General Discussion


Synta

Dignan,

Trials not for MS, but something to keep in mind.

Ian


Synta launches human trials for anti-inflammatory drug

Synta Pharmaceuticals Corp. has launched two new midstage human clinical trials to test an anti-inflammatory drug.
The Lexington, Mass.-based private company said it had began dosing patients in two separate Phase II trials regarding the compound apilimod mesylate. One trial will focus on rheumatoid arthritis and the other will target common variable immunodeficiency, a condition ...
Read more : Synta | Views : 1164 | Replies : 0 | Forum : Drug Pipeline


MS Risk Influenced by Childhood Environment

Multiple Sclerosis Risk Influenced by Childhood Environment

TORONTO, ONTARIO--(CCNMatthews - May 24, 2006) -

Study of children and adults sheds new light on mysterious disease

The Multiple Sclerosis Society of Canada announced findings from a Canadian study that shows the risk of MS may be influenced by place of residence during childhood rather than ancestry. The study results were published in a recent edition of Neuroepidemiology.

The study puts into question the belief that MS ...
Read more : MS Risk Influenced by Childhood Environment | Views : 1814 | Replies : 3 | Forum : General Discussion


B cells

I'm glad to see some research from a reputable source on B cells and MS.



B lineage cells in the inflammatory central nervous system environment: Migration, maintenance, local antibody production, and therapeutic modulation.

Ann Neurol. 2006 May 22;59(6):880-892
Meinl E, Krumbholz M, Hohlfeld R.
Department of Neuroimmunology, Max-Planck-Institute of Neurobiology, Martinsried, Munich, Germany.

B cells have long played an enigmatic role in the scenario of multiple sclerosis pathogenesis. This review summarizes recent progress in our ...
Read more : B cells | Views : 1307 | Replies : 1 | Forum : General Discussion


 

Login  •  Register


Statistics

Total posts 220799 • Total topics 22880 • Total members 14448


Contact us | Terms of Service